TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
PDSB

PDS Biotechnology Corp

Healthcare · Biotechnology

1.40$ -4.9% vs. previous close Closing price · As of: Nov 2, 2026

Ownership

Ownership Structure

Who owns PDS Biotechnology Corp (PDSB)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 61.9% of the shares are freely tradable; institutional investors hold 9.2%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 9.2%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 1.5%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 61.9%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 3.9%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 73Mio.

Largest Shareholders

Institutions

Institutions PDSB
Name Stake (%) Shares Change (%) Date
Vanguard Capital Management, LLC 2.34 1,699,315 +4.2 06/30/2026
The Colony Group LLC 0.89 642,177 +0.0 06/30/2026
Quantinno Capital Management LP 0.89 642,177 +0.0 06/30/2026
BlackRock Inc 0.84 607,639 +9.7 06/30/2026
Geode Capital Management, LLC 0.81 587,139 -11.1 06/30/2026
Vanguard Fiduciary Trust Co 0.49 357,144 +16.2 06/30/2026
Militia Capital Management, LLC 0.46 331,800 +0.0 06/30/2026
Citadel Advisors Llc 0.45 323,801 +0.0 06/30/2026
Morgan Stanley - Brokerage Accounts 0.43 313,922 +7,904.1 06/30/2026

Funds

Funds PDSB
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 1.44 1,042,050 +0.0 09/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: November 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?